A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,545 shares of TERN stock, worth $14,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,545
Previous 1,931 31.8%
Holding current value
$14,252
Previous $13,000 61.54%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$6.49 - $10.8 $3,984 - $6,631
614 Added 31.8%
2,545 $21,000
Q2 2024

Jul 30, 2024

BUY
$4.54 - $8.2 $8,766 - $15,834
1,931 New
1,931 $13,000
Q4 2023

Jan 24, 2024

BUY
$3.37 - $6.86 $363 - $740
108 Added 0.27%
40,679 $264,000
Q3 2023

Oct 26, 2023

BUY
$4.7 - $8.55 $723 - $1,316
154 Added 0.38%
40,571 $204,000
Q2 2023

Aug 10, 2023

BUY
$7.35 - $13.29 $297,064 - $537,141
40,417 New
40,417 $353,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $211M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.